Government Agencies Provide Funding For Most USPSTF Evidence Reviews

MedicalResearch.com Interview with:

Jennifer Villani, PhD, MPH Office of Disease Prevention National Institutes of Health

Dr. Villani

Jennifer Villani, PhD, MPH
Office of Disease Prevention
National Institutes of Health

MedicalResearch.com: What is the background for this study? What are the main findings? 

Response: The US Preventive Services Task Force (USPSTF) develops recommendations for the delivery of clinical preventive services based on the highest quality scientific evidence available. We performed a comprehensive assessment of the sources of funding for the research studies in this evidence base.

The results showed that government agencies supported the most articles (56%), with the remaining support coming from nonprofits or universities (32%), and industry (17%). The National Institutes of Health was the single largest funder of research articles underlying the USPSTF recommendations. 

MedicalResearch.com: What should readers take away from your report?

Response: NIH-funded research underpins many clinical preventive service recommendations made by the USPSTF. 

MedicalResearch.com: What recommendations do you have for future research as a result of this work?

Response: It is important to evaluate the funding sources for the scientific evidence base of clinical practice guidelines from professional societies and other organizations. 

MedicalResearch.com: Is there anything else you would like to add?

Response: The views expressed here are solely the opinions of the authors and do not necessarily reflect the official policies of the US Department of Health and Human Services, the National Institutes of Health, or the Agency for Healthcare Research and Quality; nor does mention of the department or agency imply endorsement by the US government. 

Citation:

Weeks WB, Kirkland KB, Freeh C, Weinstein JN. Proportion of Decedents’ Expenditures Among Recent Reductions in Medicare Expenditures. JAMA Intern Med. 2018;178(5):717–719. doi:10.1001/jamainternmed.2017.8213

 

The information on MedicalResearch.com is provided for educational purposes only, and is in no way intended to diagnose, cure, or treat any medical or other condition. Always seek the advice of your physician or other qualified health and ask your doctor any questions you may have regarding a medical condition. In addition to all other limitations and disclaimers in this agreement, service provider and its third party providers disclaim any liability or loss in connection with the content provided on this website.

 

1 Comment
  • Philip
    Posted at 12:00h, 23 June Reply

    I have been a family doctor for 40 years I have seen cancer treatment drugs and hepatitis C treatment drugs make it to Market. I have not seen blood pressure medicine or antibiotics and skin to 15 years. The last one was Levaquin was almost impossible to write because of the insurance company and it has been generic for several years. Instead of inventing new drug treatments they are now trying Coos limit antibiotics to the same drugs we used for years to try to prevent resistance from building up further. We already have MRSA and C- diff. Why is IMS a new drug if you can’t sell it. The system is going to lead to the annihilation of mankind. In the movie War of the Worlds, it was on bacteria and viruses that killed the aliens.

Post A Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.